A Newborn with hypoplastic left heart syndrome (HLHS) cannot survive without an open arterial duct and adequate inter-atrial communication. Prostaglandin infusion is usually used to keep the duct patent and balloon atrial septostomy, if needed, will be performed. Those with large inter-atrial communication may survive the first month of life, but the majority of them will gradually deteriorate and eventually die. The assumed change in pathophysiology leading to death is a reduction in pulmonary vascular resistance leading to lung congestion and less systemic perfusion ending with multi-organ failure.
To the Editor, A Newborn with hypoplastic left heart syndrome (HLHS) cannot survive without an open arterial duct and adequate inter-atrial communication. Prostaglandin infusion is usually used to keep the duct patent and balloon atrial septostomy, if needed, will be performed. Those with large inter-atrial communication may survive the first month of life, but the majority of them will gradually deteriorate and eventually die. The assumed change in pathophysiology leading to death is a reduction in pulmonary vascular resistance leading to lung congestion and less systemic perfusion ending with multi-organ failure.
Norwood cascade of surgical palliations for HLHS was first performed in the early 1980s however during the last 20 years the concept of hybrid approach was introduced. This hybrid intervention encompasses balloon atrial septostomy, and surgical banding of pulmonary artery branches combined with transluminal stenting of the arterial duct. The intervention needs to be performed in a special catheterization laboratory by both cardiac surgeons and interventional cardiologist team (1). As a result of this complex operation, the right ventricle will pump blood to pulmonary and systemic circulation. The blood passes through arterial duct will, therefore, have a high pressure, with low oxygen partial pressure (PO2). Reported disadvantages of hybrid approach include the need for antiplatelet aggregation prophylaxis, the potential risk of reverse coarctation and possibly other complications while waiting for stage II (Glenn shunt and aortic arch reconstruction) palliation (2).
During the fetal life, the arterial duct is kept open by three mechanism: 1) the elevated intravascular pressure within the arterial duct due to constricted pulmonary vascular bed and high pulmonary vascular resistance. 2) endogenous production of Prostaglandin-E2 (PG-E2)produced by the duct endothelium.
3) The increased intracellular concentration of cAMP, nitric oxide production by fetal arterial duct and increased carbon monoxide production by endothelial and smooth muscle cell of the duct play an important role to keep the duct patent (3). After delivery, several factors stimulate the duct constriction and closure, such as: increased PO2, reduced pressure within the duct lumen and decreased PG2 secretion and its receptors.
Surgical banding of pulmonary artery branches, as part of the hybrid approach, would limit blood flow through the pulmonary artery branches and direct the blood flow toward the arterial duct. This resulted in maintaining high intraluminal pressure within the duct, and the blood flowing through it will have low arterial PO2. The availability of both factors leads to a situation mimicking intrauterine status. This makes us hypothesize that the arterial duct, even without stenting, may still remain patent following pulmonary artery branch banding. We understand that this hypothesis needs to be discussed and tested further. However, it is worth to be thought about, as it might simplify the hybrid procedure and eliminate stent-related complications. We would be interested to hear the thoughts of the respective readers.
